2 Unstoppable Green Flags for AbbVie
14/4 13:00
When it comes to AbbVie (NYSE: ABBV), investors have been worrying about one thing: an eventual drop in sales of its blockbuster Humira. The immunosuppressive drug is used for various diseases, including rheumatoid arthritis....